LITTLE KNOWN FACTS ABOUT PHARMACEUTICAL EXCIPIENTS.

“As API suppliers, we're a little bit in the center,” Gomes claims. “We see what is occurring with our clients who will be generic or branded drug manufacturers, but we also see what is going on with the earliest stage of the availability chain.This route will surely not constitute an economically viable method as compared to the prevailing m